PMDA drug package insert
アポハイドローション20%
PMDA Prescription drug · 久光製薬株式会社 · package insert Jun 18, 2025
Key facts
| Brand names | アポハイドローション20% |
|---|---|
| Nonproprietary names | オキシブチニン塩酸塩 |
| Companies | 製造販売元／久光製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 原発性手掌多汗症治療剤 |
| Therapeutic category codes | 871259 |
| YJ codes | 1259702Q1026 |
| Approval numbers | 30500AMX00113000 |
| Package insert edition | 第5版 |
| Package insert date | Jun 18, 2025 |
| PMDA document key | 650034_1259702Q1026_1 |
| PMDA company code | 650034 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: